T-cell therapy (B-cell lymphoma)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameT-cell therapy (B-cell lymphoma)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Cytokine-induced killer cell
Mechanisms of ActionT-cell receptor agonists
TargetsT-cell receptor
Therapy Area/IndicationsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending
Highest Status in ChinaN/A
Originator CompaniesBoston 3t Biotechnologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoston 3t Biotechnologies
Active IndicationsN/A
Inactive IndicationsLymphoma, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A